![These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000 These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-02.jpg&id=637077)
These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000
![Visual representation of Verteporfin photodynamic therapy: injected... | Download Scientific Diagram Visual representation of Verteporfin photodynamic therapy: injected... | Download Scientific Diagram](https://www.researchgate.net/publication/221922617/figure/fig4/AS:668615137320963@1536421679061/Visual-representation-of-Verteporfin-photodynamic-therapy-injected-verteporfin.jpg)
Visual representation of Verteporfin photodynamic therapy: injected... | Download Scientific Diagram
Global Photodynamic Therapy Market Analysis & Forecast 2024-2034: Innovations in Photodynamic Therapy Devices Propel Growth, with Cancer Treatment and Skin Conditions at the Forefront
![Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem](https://www.axonmedchem.com/media/catalog/product/cache/1/image/9df78eab33525d08d6e5fb8d27136e95/3/3/3354.gif)
Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem
![A Combination of Visudyne and a Lipid‐anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer - Rizvi - 2019 - Photochemistry and Photobiology - Wiley Online Library A Combination of Visudyne and a Lipid‐anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer - Rizvi - 2019 - Photochemistry and Photobiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bf94b0b4-a8e8-4808-a042-f02448234dab/php13066-fig-0001-m.jpg)